Pharmaids Pharmaceuticals Limited (BOM:524572)
India · Delayed Price · Currency is INR 33.39
-0.05 (-0.15%)
At close: Aug 17, 2026
Pharmaids Pharmaceuticals Market Cap
Pharmaids Pharmaceuticals has a market cap or net worth of 1.18 billion as of August 17, 2026. Its market cap has decreased by -46.80% in one year.
Market Cap
1.18B
Enterprise Value
1.41B
Revenue
253.48M
Ranking
n/a
PE Ratio
n/a
Stock Price
33.39
ChartMarket Cap Chart
Since January 11, 2002, Pharmaids Pharmaceuticals's market cap has increased from 12.26M to 1.18B, an increase of 9,505.31%. That is a compound annual growth rate of 20.38%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 17, 2026 | 1.18B | -29.94% |
| Dec 31, 2025 | 1.68B | -32.38% |
| Dec 31, 2024 | 2.49B | 137.65% |
| Dec 29, 2023 | 1.05B | 185.46% |
| Dec 26, 2022 | 366.41M | 131.65% |
| Dec 31, 2021 | 158.17M | -6.80% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 9, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Parnax Lab | 1.49B |
| Speciality Medicines | 1.43B |
| Bal Pharma | 1.38B |
| Lactose (India) | 1.35B |
| Aayush Wellness | 1.16B |
| Denis Chem Lab | 978.86M |
| Concord Drugs | 960.33M |
| Makers Laboratories | 921.05M |